Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |